DarioHealth (DRIO) Director Karah Hila Receives Restricted Stock Award

What Happened
Karah Hila, a director of DarioHealth Corp. (DRIO), received a grant of 28,000 restricted shares on 2026-09-24. The reported acquisition price is $0.00 (transaction code A = award/grant). The filing reports $0 as the cash amount paid; any market value/tax consequence depends on future vesting and company stock price.

Key Details

• Transaction date: 2026-09-24; Form 4 filed: 2026-09-28 (accession 0001104659-26-111346).
• Shares granted: 28,000; reported price: $0.00; reported cash value: $0.
• Shares owned after transaction: not disclosed in the filing.
• Footnote: The restricted share award vests in eight equal quarterly installments on the last day of each successive calendar quarter after the grant date over a two-year period.
• No 10b5-1 plan, tax-withholding, or late-filing flag noted in the provided filing details.

Context
Restricted share awards are a common form of director/executive compensation and are distinct from open-market purchases or sales; they do not necessarily signal immediate insider sentiment about the stock. The award vests over time, so the director only gains full ownership gradually; tax treatment and any potential 83(b) election are not indicated in this filing.